Therapeutic options for cutaneous leishmaniasis

被引:13
|
作者
Mahajan, Vikram K. [1 ]
Sharma, Nand Lal [1 ]
机构
[1] Indira Gandhi Med Coll, Dept Dermatol Venerol & Leprosy, Shimla 171001, Himachal Prades, India
关键词
amphotericin B; cutaneous leishmaniasis; dapsone; imidazoles; miltefosine; rifampicin; sodium stibogluconate;
D O I
10.1080/09546630601159474
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Cutaneous leishmaniasis occurs worldwide in both old and new world countries with their own endemic foci. Many of those infected often experience a delay in diagnosis and inappropriate treatment. Objectives: To review the literature in terms of the various treatment options described for cutaneous leishmaniasis. Methods: Literature on the treatment of cutaneous leishmaniasis retrieved by searching Index Medicus, PubMed and IndMed were reviewed. Results and conclusion: Review reveals no uniform pattern or definite guidelines for its therapy. The varied and contradictory experience of different workers further confounds the clinicians involved in the care of these patients. Selection of an appropriate and customized treatment schedule is a discretion the treating clinician has to make.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [31] Enhancing the therapeutic landscape of cutaneous leishmaniasis: pegylated liposomal delivery of miltefosine for controlled release and improved efficacy
    Alharthi, Sitah
    Alrashidi, Amal Abdullah
    Alavi, Seyed Zeinab
    Alotaibi, Ghallab
    Raza, Aun
    Zahra, Gull E.
    Shahmabadi, Hasan Ebrahimi
    Alavi, Seyed Ebrahim
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 96
  • [32] Treatment options for leishmaniasis
    Pradhan, S.
    Schwartz, R. A.
    Patil, A.
    Grabbe, S.
    Goldust, M.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (03) : 516 - 521
  • [33] Topical tamoxifen in the therapy of cutaneous leishmaniasis
    Trinconi, Cristiana T.
    Reimao, Juliana Q.
    Bonano, Vivian, I
    Espada, Caroline R.
    Miguel, Danilo C.
    Yokoyama-Yasunaka, Jenicer K. U.
    Uliana, Silvia R. B.
    PARASITOLOGY, 2018, 145 (04) : 490 - 496
  • [34] New developments in the treatment of cutaneous leishmaniasis
    Dinc, Rasit
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2022, 15 (05) : 196 - 205
  • [35] Cutaneous Leishmaniasis Due to Leishmania aethiopica
    van Henten, Saskia
    Adriaensen, Wim
    Fikre, Helina
    Akuffo, Hannah
    Diro, Ermias
    Hailu, Asrat
    Van der Auwera, Gert
    van Griensven, Johan
    ECLINICALMEDICINE, 2018, 6 : 69 - 81
  • [36] Current Treatment for Cutaneous Leishmaniasis: A Review
    Palumbo, Emilio
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (02) : 178 - 182
  • [37] Therapeutic Modalities in Post Kala-azar Dermal Leishmaniasis: A Systematic Review of the Effectiveness and Safety of the Treatment Options
    Datta, Adrija
    Podder, Indrashis
    Das, Anupam
    Sil, Amrita
    Das, Nilay Kanti
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (01) : 34 - 43
  • [38] Treatment Options for Visceral Leishmaniasis and HIV coinfection
    Monge-Maillo, Begona
    Lopez-Velez, Rogelio
    AIDS REVIEWS, 2016, 18 (01) : 32 - 43
  • [39] Comparative assessment of interventions for treating cutaneous leishmaniasis: A network meta-analysis of randomized clinical trials.
    Sridharan, Kannan
    Sivaramakrishnan, Gowri
    ACTA TROPICA, 2021, 220
  • [40] Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients
    Ollech, Ayelet
    Solomon, Michal
    Horev, Amir
    Reiss-Huss, Shiran
    Ben-Amitai, Dan
    Zvulunov, Alex
    Friedland, Rivka
    Atar-Snir, Vered
    Molho-Pessach, Vered
    Barzilai, Aviv
    Greenberger, Shoshana
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 1 - 5